Literature DB >> 17038284

Instant 99mTc-ciprofloxacin scintigraphy for the diagnosis of osteomyelitis in the diabetic foot.

Pinaki Dutta1, Anil Bhansali, Bhagwant R Mittal, Baljnder Singh, Sariq R Masoodi.   

Abstract

BACKGROUND: The diagnosis of osteomyelitis of the foot in patients with diabetes mellitus remains a challenge. This study was conducted to evaluate bone infections using scintigraphy with instantly prepared single-vial kit, radio-labeled ciprofloxacin (Diagnobact TM) in comparison to a bacterial culture taken from the involved site.
METHODS: Twenty-five patients with type 2 diabetes mellitus having foot ulcers, including six with superficial ulcers and positive 99mTc-methylene diphosphonate (MDP) bone scan as a control, were subjected to 99mTc-ciprofloxacin scan and subsequent bacteriological culture.
RESULTS: 99mTc-ciprofloxacin scan was positive in 13 patients and negative in 12 patients, including the six with superficial ulcers. Bacterial culture was positive in 18 patients and negative in seven, including one with osteomyelitis on bone biopsy only. 99mTc-ciprofloxacin scan showed "true positive" results in 12, "true negative" in six, "false positive" in one, and "false negative" in six. The specificity and sensitivity of the test were 66.7% and 85.7%, respectively. The positive and negative predictive values and an accuracy of 92.8%, 50% and 72%, respectively. Staphylococcus aureus and Escherichia coli were the most frequently isolated organisms.
CONCLUSION: 99mTc-ciprofloxacin is a sensitive and specific marker to diagnose bone infection in patients with diabetes mellitus, but care must be taken in case of fastidious organisms and ciprofloxacin-resistant bacterial flora in which false results may be obtained.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17038284     DOI: 10.1177/107110070602700911

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  5 in total

Review 1.  Fluoroquinolones as imaging agents for bacterial infection.

Authors:  Syed Ali Raza Naqvi; Karl Drlica
Journal:  Dalton Trans       Date:  2017-10-31       Impact factor: 4.390

2.  Utility of ⁹⁹mTc-labelled antimicrobial peptide ubiquicidin (29-41) in the diagnosis of diabetic foot infection.

Authors:  Shabana Saeed; Jamal Zafar; Bashar Khan; Ali Akhtar; Sumair Qurieshi; Shazia Fatima; Naseer Ahmad; Javed Irfanullah
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-30       Impact factor: 9.236

3.  Design, Preparation, and Evaluation of a Novel 99mTcN Complex of Ciprofloxacin Xanthate as a Potential Bacterial Infection Imaging Agent.

Authors:  Si'an Fang; Yuhao Jiang; Qianqian Gan; Qing Ruan; Di Xiao; Junbo Zhang
Journal:  Molecules       Date:  2020-12-10       Impact factor: 4.411

Review 4.  Pathophysiology and Molecular Imaging of Diabetic Foot Infections.

Authors:  Katie Rubitschung; Amber Sherwood; Andrew P Crisologo; Kavita Bhavan; Robert W Haley; Dane K Wukich; Laila Castellino; Helena Hwang; Javier La Fontaine; Avneesh Chhabra; Lawrence Lavery; Orhan K Öz
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

Review 5.  Imaging bacteria with radiolabelled quinolones, cephalosporins and siderophores for imaging infection: a systematic review.

Authors:  S Auletta; F Galli; C Lauri; D Martinelli; I Santino; Alberto Signore
Journal:  Clin Transl Imaging       Date:  2016-07-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.